R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2

Summary

In the second instalment in this bi-monthly series, Alex Simpson and Sreeram Ramagopalan (both F. Hoffmann-La Roche, Basel, Switzerland) discuss the impact of COVID-19 on access to real-world data, as well as how these data can be used to address health inequity, an area of increasing interest for health technology assessment.

Catch up with the first instalment in this series here >>>